FDA Gives 7 Companies Go Ahead To Market Generic Plavix

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix.

Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to prevent, as well as gastrointestinal bleeding, bleeding ulcers, cerebral bleeding, thrombotic thrombocytopenic purpura (TTP), and other problems.

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.